RDF Representation using POMR of Patient 1

Slides:

Advertisements

Similar presentations

Hypertension NPN 200 Medical Surgical I. Description of Hypertension Intermittent or sustained elevation in the diastolic or systolic blood pressure:

Advertisements

Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.

Vital Signs/Blood pressure. Blood Pressure Arterial blood pressure is a measure of pressure exerted by the blood as flows through the arteries. (measured.

Fluids and Electrolytes

MANAGEMENT HTN IN PREGNANCY. DEFINITIONS The definition of gestational hypertension is somewhat controversial. Some clinicians therefore recommend close.

Ambulatory Care Pharmacy

BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.

Arterial blood pressure is a measure of the pressure exerted by the blood as it flows through the arteries. The systolic pressure is the pressure of the.

NYU Medical Grand Rounds Clinical Vignette Karyn Singer, PGY3 September 22, 2010 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.

Blood pressure control in primary health care WORKSHOP

Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine

AN INTERDISCIPLINARY APPROACH TO OLDER ADULT FALL PREVENTION April 15, 2015 Sponsored by The Geriatrics and Gerontology Education and Research Program,

Clinical Correlations The NYU Langone Online Journal of Medicine

Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.

-Greatest Achievements in Endocrinology – Jose Mario F. de Oliveira, MD, Ph.D. -Brigham&Womens Hospital – Endocrinology, Hypertension&Diabetes Division.

Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.

To assess the prognostic value of variability in home-measured blood pressure (BP) and heart rate (HR) in a general population. Objective: Methods: BP.

Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:

לדיובן הגנה כלייתית מוכחת בחולי סכרת מסוג 2, (היפרטנסיבים ונורמוטנסיבים) עם מיקרואלבומינוריה לדיובן הגנה כלייתית מוכחת בחולי סכרת מסוג 2, (היפרטנסיבים.

بسم الله الرحمن الرحيم. Adult Hodgkin’s Lymphoma in the Eastern Part of Libya Dr. M.Mangoush, R. Nafo, S.Kardah, M.Letaiwish, S.Kardah, F.Bodabous, S.Ebkhatra.

HTN Cases Pharmacotherapy - 1. Case 1 TJ is a 45-year-old woman with a history of type 2 diabetes mellitus treated with glyburide 5 mg/ day. She.

Case I A 47 old male presents to your office for a yearly checkup. He smokes 40 cigarette/day, and examination detect wheezy chest and bronchospasm. His.

J.T. is a 62-year-old man with a history of CAD (MI 3 years ago), hypertension, depression, chronic renal insufficiency (baseline SCr is 2.8 mg/dL), peripheral.

미 국 에 서 의 병 원 약 사 의 역 할 서 옥 경, Pharm.D. 서울대학교 약학대학.

Please get your assigned computer. Do not turn on until instructed.

“Vital Signs are…Vital!” Jennifer Lyon, M.S., M.L.I.S.

Journal Club February 7, 2014 Sadie T. Velásquez, MD.

Pharmacy in Public Health: Describing Populations Course, date, etc. info.

Category Sex Systolic BP (mmHg) Men (n=58) Women (n=106) P value

Oconee Physical Therapy and Sports Rehabilitation

Copyright © 1999 American Medical Association. All rights reserved.

Dr John Cox Diabetes in Primary Care Conference Cork

Oconee Physical Therapy and Sports Rehabilitation

Creating RDF Representations of Patient Data

RDF Representation using POMR of Patient 1

Basics of New PHASE Reporting

Hypertension JNC VIII Guidelines.

Baseline characteristics and effectiveness results

LIVE CASE PRESENTATION MOUNT SINAI CARDIAC CATH LAB

Test for orthostatic hypotension

Real-world Clinical Outcomes Among Patients With Type 2 Diabetes Receiving Canagliflozin at a Specialty Diabetes Clinic: Subgroup Analysis by Baseline.

Copyright © 2007 American Medical Association. All rights reserved.

HTN Cases Pharmacotherapy - 1.

EMPHASIS-HF Extended Follow-up

Primary Efficacy End Point.

Blood Pressure August 2015 Blood Pressure.

P1 rdf:type pomr:PatientRecord rdf:type galen:Patient

Mean BP from initial visit to four years

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Jean L. Chan, MD, Martin J. Abrahamson, MD Mayo Clinic Proceedings

Emerging Mechanisms in Glucose Metabolism

The Hypertension in the Very Elderly Trial (HYVET)

Step Care Therapy for Hypertension in Diabetic Patients

P1 rdf:type pomr:PatientRecord rdf:type galen:Patient

Time point Difference in systolic BP (mm Hg) p

Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.

RDF Representation using Detailed Clinical Models of Patient 1

Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.

Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010

How would you approach this patient?

Train-the-Trainer Cases

Range of mean changes from baseline in A1C in clinical studies of 24–52 weeks’ duration reported in prescribing information for five GLP-1 receptor agonists.

Flow chart of the 1683 study members at age 60–64 years by hypertension (HT) status. Flow chart of the 1683 study members at age 60–64 years by hypertension.

Train-the-Trainer Cases

Train-the-Trainer Cases

Volume 75, Issue 1, Pages (January 2009)

Pseudopheochromocytoma Secondary to Brimonidine Ophthalmic Solution

End point Valsartan Valsartan+HCTZ p

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

RDF Representation using POMR of Patient 1

54-year-old man with diabetes was referred to the Hypertension Clinic in Jichi Medical School Hospital with symptoms of dizziness and orthostatic intolerance. In 2002, he started insulin therapy (Hemoglobin A1c 9 %), and in 2004, he was started on a once daily dose of valsartan 80 mg for hypertension. He sometimes complained of dizziness and fainting while standing. On 13 February 2005, he fell down while riding a bicycle. As the clinic BP was 84/60 mm Hg on 14 March, and the valsartan was stopped. He was referred to otolaryngology and neurology, but no significant abnormalities were detected.

Informal “Triples” Patient P1 P1 sex male P1 age 54 P1 disease diabetes P1 referred-to "Hypertension Clinic" "Hypertension Clinic" department-of "Jichi Medical School Hospital" P1 symptom dizziness P1 symptom "orthostatic intolerance" [P1 therapy "Insulin Therapy"] [...] started-in 2002 [P1 lab-result HemoglobinA1c] [...] value 9% [...] measurement-date 2002 [P1 therapy Valsartan] [...] dose 80mg [...] frequency "Once Daily" [...] started 2004 [...] stopped "14 March 2005" [P1 symptom dizziness] [...] frequency Sometimes [P1 symptom fainting] [...] position "while standing" [P1 history "fall"] [...] activity "riding a bicycle" [P1 vital-sign BP] [...] systolic 84 [...] diastolic 60 [...] measurement-date "14 March 2005" P1 referred-to otolaryngology P1 referred-to neurology not ([P1 clinical-finding abnormality] [...] emphasis significant)

P1 rdf:type pomr:PatientRecord rdf:type galen:Patient galen:hasPhenotypicalSex sex1 rdf:type galen:PhenotypicalSex galen:hasAbsoluteState galen:hasAge sexState1 rdf:type galen:maleSex age1 rdf:type galen:Age galen:isActedOnSpecificallyBy galen:hasRange range1 rdf:type galen:Range disease1 rdf:type galen:DiabetesMellitus galen:hasStartPoint galen:hasEndPoint point1 rdf:type galen:PointTemporalValue galen:hasNumber galen:hasUnits n54 years

P1 rdf:type pomr:PatientRecord rdf:type galen:Patient referral1: rdf:type galen:ReferralAct galen:isActedOnSpecificallyBy /* couldn’t figure out how to reach a clinic */ galen:hasSymptom galen:hasSymptom symptom1 rdf:type myModel:DizzinessSymptom symptom2 rdf:type myModel:OrthostaticIntoleranceSymptom

P1 rdf:type pomr:PatientRecord rdf:type galen:Patient galen:ClinicalRecordAttribute galen:occursDuring therapy1 rdf:type galen:DrugAdministration timePeriod1 rdf:type galen:TimePeriod